BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34930015)

  • 1. Long-Term Outcomes After Melody Transcatheter Pulmonary Valve Replacement in the US Investigational Device Exemption Trial.
    Jones TK; McElhinney DB; Vincent JA; Hellenbrand WE; Cheatham JP; Berman DP; Zahn EM; Khan DM; Rhodes JF; Weng S; Bergersen LJ
    Circ Cardiovasc Interv; 2022 Jan; 15(1):e010852. PubMed ID: 34930015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial.
    Cheatham JP; Hellenbrand WE; Zahn EM; Jones TK; Berman DP; Vincent JA; McElhinney DB
    Circulation; 2015 Jun; 131(22):1960-70. PubMed ID: 25944758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study.
    Armstrong AK; Balzer DT; Cabalka AK; Gray RG; Javois AJ; Moore JW; Rome JJ; Turner DR; Zellers TM; Kreutzer J
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1254-62. PubMed ID: 25459038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes After Transcatheter Reintervention for Dysfunction of a Previously Implanted Transcatheter Pulmonary Valve.
    Shahanavaz S; Berger F; Jones TK; Kreutzer J; Vincent JA; Eicken A; Bergersen L; Rome JJ; Zahn E; Søndergaard L; Cheatham JP; Weng S; Balzer D; McElhinney D
    JACC Cardiovasc Interv; 2020 Jul; 13(13):1529-1540. PubMed ID: 32646693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocarditis After Transcatheter Pulmonary Valve Replacement.
    McElhinney DB; Sondergaard L; Armstrong AK; Bergersen L; Padera RF; Balzer DT; Lung TH; Berger F; Zahn EM; Gray RG; Hellenbrand WE; Kreutzer J; Eicken A; Jones TK; Ewert P
    J Am Coll Cardiol; 2018 Dec; 72(22):2717-2728. PubMed ID: 30497557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: A multicenter study.
    Cabalka AK; Asnes JD; Balzer DT; Cheatham JP; Gillespie MJ; Jones TK; Justino H; Kim DW; Lung TH; Turner DR; McElhinney DB
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1712-1724.e1. PubMed ID: 29395214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melody transcatheter pulmonary valve replacement: a single-center case series in Southeast Asia.
    Satawiriya M; Chandavimol M; Limsuwan A
    BMC Cardiovasc Disord; 2024 Jun; 24(1):301. PubMed ID: 38872098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US Melody Valve Trial.
    McElhinney DB; Cheatham JP; Jones TK; Lock JE; Vincent JA; Zahn EM; Hellenbrand WE
    Circ Cardiovasc Interv; 2011 Dec; 4(6):602-14. PubMed ID: 22075927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation of the Melody transcatheter pulmonary valve PB1016 in patients with dysfunctional right ventricular outflow tract conduits.
    Morray BH; Jones TK; Coe JY; Gitter R; Martinez JZ; Turner DR; Gray RG; Lung TH; Berman DP; Levi DS
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):474-480. PubMed ID: 30419603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the investigational device exemption and post-approval trials of the Melody transcatheter pulmonary valve.
    Kreutzer J; Armstrong AK; Rome JJ; Zellers TM; Balzer DT; Zampi JD; Cabalka AK; Javois AJ; Turner DR; Gray RG; Moore JW; Weng S; Jones TK; Khan DM; Vincent JA; Hellenbrand WE; Cheatham JP; Bergersen LJ; McElhinney DB
    Catheter Cardiovasc Interv; 2021 Aug; 98(2):E262-E274. PubMed ID: 33780150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between patient age at implant and outcomes after transcatheter pulmonary valve replacement in the multicenter Melody valve trials.
    Armstrong AK; Berger F; Jones TK; Moore JW; Benson LN; Cheatham JP; Turner DR; Rhodes JF; Vincent JA; Zellers T; Lung TH; Eicken A; McElhinney DB
    Catheter Cardiovasc Interv; 2019 Oct; 94(4):607-617. PubMed ID: 31419019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial.
    McElhinney DB; Hellenbrand WE; Zahn EM; Jones TK; Cheatham JP; Lock JE; Vincent JA
    Circulation; 2010 Aug; 122(5):507-16. PubMed ID: 20644013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience and Outcomes of Surgically Implanted Melody Valve in the Pulmonary Position.
    Feins EN; Chávez M; Callahan R; Del Nido PJ; Emani SM; Baird CW
    Ann Thorac Surg; 2021 Mar; 111(3):966-972. PubMed ID: 32603706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter Pulmonary Valve Replacement With the Melody Valve in Small Diameter Expandable Right Ventricular Outflow Tract Conduits.
    Shahanavaz S; Qureshi AM; Levi DS; Boudjemline Y; Peng LF; Martin MH; Bauser-Heaton H; Keeshan B; Asnes JD; Jones TK; Justino H; Aboulhosn JA; Gray RG; Nguyen H; Balzer DT; McElhinney DB
    JACC Cardiovasc Interv; 2018 Mar; 11(6):554-564. PubMed ID: 29566801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter Pulmonary Valve Replacement for Right Ventricular Outflow Tract Conduit Dysfunction After the Ross Procedure.
    Gillespie MJ; McElhinney DB; Kreutzer J; Hellenbrand WE; El-Said H; Ewert P; Rhodes JF; Søndergaard L; Jones TK
    Ann Thorac Surg; 2015 Sep; 100(3):996-1002; discussion 1002-3. PubMed ID: 26190388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of transcatheter pulmonary valve implantation with melody and SAPIEN valves.
    Houeijeh A; Batteux C; Karsenty C; Ramdane N; Lecerf F; Valdeolmillos E; Lourtet-Hascoet J; Cohen S; Belli E; Petit J; Hascoët S
    Int J Cardiol; 2023 Jan; 370():156-166. PubMed ID: 36283540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-Year Outcomes From the Harmony Native Outflow Tract Early Feasibility Study.
    Benson LN; Gillespie MJ; Bergersen L; Cheatham SL; Hor KN; Horlick EM; Weng S; McHenry BT; Osten MD; Powell AJ; Cheatham JP
    Circ Cardiovasc Interv; 2020 Jan; 13(1):e008320. PubMed ID: 32525412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous pulmonary Melody
    Bensemlali M; Malekzadeh-Milani S; Mostefa-Kara M; Bonnet D; Boudjemline Y
    Arch Cardiovasc Dis; 2017 Oct; 110(10):517-524. PubMed ID: 28549918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leaflet morphology classification of the Melody Transcatheter Pulmonary Valve.
    Boe BA; Cheatham SL; Armstrong AK; Berman DP; Chisolm JL; Cheatham JP
    Congenit Heart Dis; 2019 Mar; 14(2):297-304. PubMed ID: 30548926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NuMED Covered Cheatham-Platinum Stent™ for the treatment or prevention of right ventricular outflow tract conduit disruption during transcatheter pulmonary valve replacement.
    Bishnoi RN; Jones TK; Kreutzer J; Ringel RE
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):421-7. PubMed ID: 25257401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.